The American pharmaceuticals giant Bristol Myers Squibb has announced plans to acquire the cancer drug therapeutics group Celgene in the 74-billion-dollar deal.

美国制药业巨头百时美施贵宝公司宣布计划收购研制抗癌药物的公司--新基生物制药，收购价格为740亿美元。